![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Bentham Science Publishers
E-ISSN: 1873-5576|10|2|155-167
ISSN: 1568-0096
Source: Current Cancer Drug Targets, Vol.10, Iss.2, 2010-03, pp. : 155-167
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Lenalidomide delays multiple myeloma progression
Inpharma, Vol. 1, Iss. 1525, 2006-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Lenalidomide in Myelodysplastic Syndrome and Multiple Myeloma
Drugs, Vol. 67, Iss. 13, 2007-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Dexamethasone/lenalidomide: Various toxicities: 3 case reports
Reactions Weekly, Vol. 1, Iss. 1354, 2011-01 ,pp. :